Benlysta to be fast-tracked by FDA
August 20, 2010Sales and Marketing Benlysta, GSK, HGS, Lupus
New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …
Kowa launches new statin in the UK
August 20, 2010Sales and Marketing Kowa, Recordati, cv, statin
A new statin has been launched in the UK by Japanese pharma company Kowa.Livazo (pitavastatin) has been approved by the …
Rupert Potter joins Incuna
August 20, 2010Medical Communications, Sales and Marketing Incuna, appointment, medical communications, sales and marketing
Rupert Potter has been appointed sales director at digital agency Incuna, where he will be responsible for a number of key …
ASCO 2010: The Hedgehog Pathway and other ways to target cancer
August 19, 2010Research and Development ASCO, Cancer, thyroid cancer
The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
Chris Hare appointed new Managing Director of Woolley Pau
August 19, 2010Medical Communications Woolley Pau, appointment, medical communications
Chris Hare, former vice president of international client services at GyroHSR, has been appointed managing director of Woolley Pau. He …
Novartis and Quark sign gene silencing deal
August 19, 2010Research and Development Novartis, Quark, SiRNA, rnai
Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …
BMS’ melanoma drug given priority review
August 19, 2010Sales and Marketing BMS, ipilimumab
Bristol-Myers Squibb’s promising new treatment for skin cancer melanoma has been given a priority review by the FDA. The company …
Cell therapy industry partnership launched
August 18, 2010Research and Development Genzyme, ISCT, Lonza, Roche
Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
Contract research news in brief
August 18, 2010Research and Development Anavex, Cyprotex, Synexus
UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …
FDA already notified on ProAmatine withdrawal, says Shire
August 18, 2010Sales and Marketing FDA, ProAmatine, Shire
Shire is to withdraw its product ProAmatine following a demand from the FDA early this week regarding post-marketing data on …
Lilly abandons late stage Alzheimer’s drug
August 17, 2010Research and Development Alzheimer's, lilly
Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
BAC and Octapharma extend collaboration for G-CSF custom ligand
August 17, 2010Manufacturing and Production BAC, Octapharma
BAC, a specialist in antibody-based affinity purification technology has signed a licence agreement with Octapharma, which manufactures human proteins for …
FDA considers pulling ProAmantine
August 17, 2010Sales and Marketing FDA, Shire, post-marketing
Shire’s low blood pressure drug ProAmantine and generic copies could be withdrawn from the US market because no post-marketing studies …
AstraZeneca staff to strike over pension cuts
August 17, 2010Sales and Marketing AstraZeneca, pensions
AstraZeneca is reviewing its position after UK trade union members at the company voted to strike over cuts to pension …
Digital Pharma: Roche asks employees to be social media ‘scouts’
August 17, 2010Medical Communications Digital Pharma blog, Roche, social media
Roche wants employees who use social media to be ‘scouts’ for how the company and its products are perceived online. …
Biocatalyst firm Codexis posts sales increase
August 16, 2010Manufacturing and Production Codexis, biocatalyst
Codexis has reported a healthy increase in revenues in the second quarter of 2010 which suggests that pharmaceutical companies are …
Patient group sponsorship and transparency criticised
August 16, 2010Sales and Marketing EMA, ethics, patient groups, transparency
High rates of sponsorship from pharma groups for patient groups have been criticised in a new report. The report from …
Regenerative medicine: small steps towards the great leap forward
August 16, 2010Research and Development GSK, Pfizer, Stem cells, regenerative medicine
Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …
Merck signs Alzheimer’s deal with Alectos
August 16, 2010Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co
Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
Emergency contraceptive proves controversial in US
August 16, 2010Sales and Marketing Ella, Plan B, Watson, emergency contraceptive
The FDA has approved HRA Pharma’s emergency contraceptive pill Ella but has been criticised by conservative ‘pro-life’ groups. French company …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
